北陆药业
(300016)
| 流通市值：34.97亿 | | | 总市值：35.03亿 |
| 流通股本：4.91亿 | | | 总股本：4.92亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 729,717,058.01 | 473,930,074.54 | 207,506,078.84 | 890,718,122.26 |
| 营业收入 | 729,717,058.01 | 473,930,074.54 | 207,506,078.84 | 890,718,122.26 |
| 二、营业总成本 | 705,505,413.93 | 452,058,612.63 | 191,504,388.32 | 947,665,868.11 |
| 营业成本 | 364,595,629.66 | 233,585,002.93 | 92,106,036.82 | 472,008,176.2 |
| 税金及附加 | 9,244,813.93 | 6,172,201.64 | 2,694,548.49 | 10,285,002.36 |
| 销售费用 | 177,551,992.89 | 112,925,510.32 | 52,046,830.73 | 217,045,570.56 |
| 管理费用 | 61,030,989.95 | 39,154,275.48 | 18,047,690.4 | 81,738,350.34 |
| 研发费用 | 53,171,942.94 | 35,451,885.44 | 13,889,933.57 | 122,328,869.24 |
| 财务费用 | 39,910,044.56 | 24,769,736.82 | 12,719,348.31 | 44,259,899.41 |
| 其中:利息费用 | 44,025,789.99 | 28,159,654.2 | 13,761,185.02 | 53,138,033.57 |
| 其中:利息收入 | 4,479,201.24 | 3,386,843.34 | 1,682,757.62 | 11,820,546.99 |
| 加:公允价值变动收益 | -13,453,704.36 | -8,906,725.89 | -3,683,666.3 | -13,956,107.18 |
| 加:投资收益 | 5,746,021.26 | 3,779,391.65 | 849,798.08 | 5,991,812.84 |
| 资产处置收益 | 1,818.3 | 1,818.3 | 1,818.3 | 894,314.78 |
| 资产减值损失(新) | -3,782,649.19 | -3,221,910.06 | -834,083.93 | -45,180,929.1 |
| 信用减值损失(新) | 1,992,546.25 | 566,922.02 | 879,631.06 | -3,833,964.77 |
| 其他收益 | 8,187,909.05 | 6,510,135.74 | 2,647,463.49 | 12,593,788.99 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 22,903,585.39 | 20,601,093.67 | 15,862,651.22 | -100,438,830.29 |
| 加:营业外收入 | 566,850.65 | 100,532.12 | 49,318.58 | 1,767,877.55 |
| 减:营业外支出 | 1,395,205.72 | 266,214.16 | 3,714.54 | 2,483,730.91 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 22,075,230.32 | 20,435,411.63 | 15,908,255.26 | -101,154,683.65 |
| 减:所得税费用 | 3,071,597.96 | 5,235,740.4 | 4,287,015.14 | -17,954,112.6 |
| 六、净利润 | 19,003,632.36 | 15,199,671.23 | 11,621,240.12 | -83,200,571.05 |
| 持续经营净利润 | 19,003,632.36 | 15,199,671.23 | 11,621,240.12 | -83,200,571.05 |
| 归属于母公司股东的净利润 | 24,394,304.8 | 19,541,206.25 | 11,526,165 | -71,757,140.03 |
| 少数股东损益 | -5,390,672.44 | -4,341,535.02 | 95,075.12 | -11,443,431.02 |
| (一)基本每股收益 | 0.05 | 0.04 | 0.02 | -0.15 |
| (二)稀释每股收益 | 0.1 | 0.07 | 0.04 | -0.07 |
| 九、综合收益总额 | 19,003,632.36 | 15,199,671.23 | 11,621,240.12 | -83,200,571.05 |
| 归属于母公司股东的综合收益总额 | 24,394,304.8 | 19,541,206.25 | 11,526,165 | -71,757,140.03 |
| 归属于少数股东的综合收益总额 | -5,390,672.44 | -4,341,535.02 | 95,075.12 | -11,443,431.02 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-22 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |